Profil
Guru Reddy is the founder of Pangene Corp.
Currently, Dr. Reddy is Vice President-Preclinical Research & Development at Unicycive Therapeutics, Inc. since 2022.
Formerly, Dr. Reddy was Vice President-Preclinical Research & Development at Spectrum Pharmaceuticals, Inc. Education includes a doctorate from Savitribai Phule Pune University.
Aktive Positionen von Guru Reddy
| Unternehmen | Position | Beginn |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von Guru Reddy
| Unternehmen | Position | Ende |
|---|---|---|
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | Gründer | - |
| SPECTRUM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Guru Reddy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | Health Technology |
Savitribai Phule Pune University
Savitribai Phule Pune University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
















